106 results on '"Bellanger, L."'
Search Results
2. Genetically tailored magnetosomes used as MRI probe for molecular imaging of brain tumor
- Author
-
Boucher, M., Geffroy, F., Prévéral, S., Bellanger, L., Selingue, E., Adryanczyk-Perrier, G., Péan, M., Lefèvre, C.T., Pignol, D., Ginet, N., and Mériaux, S.
- Published
- 2017
- Full Text
- View/download PDF
3. Validation sur le terrain du nouveau test de diagnostic rapide Ebola eZYSCREEN®
- Author
-
Gallais, F., Gay-Andrieu, F., Picot, V., Magassouba, N., Mély, S., Peyrefitte, C. N., and Bellanger, L.
- Published
- 2017
- Full Text
- View/download PDF
4. A Statistical Approach for Dating Archaeological Context
- Author
-
Bellanger, L., primary, Tomassone, R., additional, and Husi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
5. Comparaison de méthodes de clustering pour détecter des troubles de la marche à partir de données issues d’un capteur de mouvement
- Author
-
Drouin, P., primary, Stamm, A., additional, Chevreuil, L., additional, Graillot, V., additional, and Bellanger, L., additional
- Published
- 2020
- Full Text
- View/download PDF
6. Development and evaluation of a genome-wide Coffee 8.5K SNP array and its application for high-density genetic mapping and for investigating the origin of Coffea arabica L
- Author
-
Merot-L'anthoene, V., Tournebize, R., Darracq, O., Rattina, V., Lepelley, M., Bellanger, L., Dubreuil Tranchant, Christine, Coulee, M., Pegard, M., Metairon, S., Fournier, C., Stoffelen, P., Janssens, S. B., Kiwuka, C., Musoli, P., Sumirat, U., Legnate, H., Kambale, J. L., Neto, J. F. D., Revel, C., Kochko, Alexandre de, Descombes, P., Crouzillat, D., and Poncet, Valérie
- Subjects
Coffea arabica origin ,C. eugenioides ,C. canephora ,genetic map ,single-nucleotide polymorphism ,SNP array - Abstract
Coffee species such as Coffea canephora P. (Robusta) and C. arabica L. (Arabica) are important cash crops in tropical regions around the world. C. arabica is an allotetraploid (2n = 4x = 44) originating from a hybridization event of the two diploid species C. canephora and C. eugenioides (2n = 2x = 22). Interestingly, these progenitor species harbour a greater level of genetic variability and are an important source of genes to broaden the narrow Arabica genetic base. Here, we describe the development, evaluation and use of a single-nucleotide polymorphism (SNP) array for coffee trees. A total of 8580 unique and informative SNPs were selected from C. canephora and C. arabica sequencing data, with 40% of the SNP located in annotated genes. In particular, this array contains 227 markers associated to 149 genes and traits of agronomic importance. Among these, 7065 SNPs (82.3%) were scorable and evenly distributed over the genome with a mean distance of 54.4 Kb between markers. With this array, we improved the Robusta high-density genetic map by adding 1307 SNP markers, whereas 945 SNPs were found segregating in the Arabica mapping progeny. A panel of C. canephora accessions was successfully discriminated and over 70% of the SNP markers were transferable across the three species. Furthermore, the canephora-derived subgenome of C. arabica was shown to be more closely related to C. canephora accessions from northern Uganda than to other current populations. These validated SNP markers and high-density genetic maps will be useful to molecular genetics and for innovative approaches in coffee breeding.
- Published
- 2019
7. Développement de méthodes innovantes utilisant un capteur de mouvement pour la détection de troubles de la marche
- Author
-
Drouin, P., primary, Chevreuil, L., additional, and Bellanger, L., additional
- Published
- 2019
- Full Text
- View/download PDF
8. L'autonomie des salariés au regard de l'introduction des TIC dans la formation à distance.
- Author
-
Cocandeau-Bellanger, L. and Vaissier, A.
- Published
- 2018
9. Crystal structure of AdTx1 (rho-Da1a) from eastern green mamba (Dendroaspis angusticeps)
- Author
-
Stura, E.A., primary, Vera, L., additional, Maiga, A.A., additional, Marchetti, C., additional, Lorphelin, A., additional, Bellanger, L., additional, Servant, D., additional, and Gilles, N., additional
- Published
- 2013
- Full Text
- View/download PDF
10. Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop.
- Author
-
Bjerner, J, Lebedin, Y, Bellanger, L, Kuroki, M, Shively, J E, Varaas, T, Nustad, K, Hammarström, Sten, Børmer, O P, Bjerner, J, Lebedin, Y, Bellanger, L, Kuroki, M, Shively, J E, Varaas, T, Nustad, K, Hammarström, Sten, and Børmer, O P
- Abstract
To characterize antigenic sites in carcinoembryonic antigen (CEA) further and to investigate whether there are differences between colon tumor CEA and meconium CEA (NCA-2) that can be detected by anti-CEA monoclonal antibodies (MAb), 19 new anti-CEA MAb were analyzed with respect to specificity, epitope reactivity and affinity. Their reactivities were compared with 10 anti-CEA MAb with known CEA-domain binding specificity that have previously been classified into five nonoverlapping epitope groups, GOLD 1-5. Cross-inhibition assays with antigen-coated microtiter plates and immunoradiometric assays were performed in almost all combinations of MAbs, using conventionally purified CEA (domain structure: N-A1B1-A2B2-A3B3-C) from liver metastasis of colorectal carcinomas, recombinant CEA, meconium CEA (NCA-2), truncated forms of CEA and NCA (CEACAM6) as the antigens. The affinity of the MAbs for CEA was also determined. The new MAbs were generally of high affinity and suitable for immunoassays. Three new MAbs were assigned to GOLD epitope group 5 (N-domain binding), 3 MAbs to group 4 (A1B1 domain), 1 to group 3 (A3B3 domain), 3 to group 2 (A2B2 domain) and 3 to group 1 (also the A3B3 domain). Three MAbs formed a separate group related to group 4, they were classified as GOLD 4' (A1B1 domain binding). The remaining 3 MAbs appear to represent new subspecificities with some relationship to GOLD groups 1, 2 or 4, respectively. Five MAbs, all belonging to epitope group 1 and 3, reacted strongly with tumor CEA but only weakly or not at all with meconium CEA, demonstrating that the two products of the CEA gene differ from each other, probably due to different posttranslational modifications.
- Published
- 2002
- Full Text
- View/download PDF
11. Immunohistochemical characterization of 30 monoclonal antibodies against cytokeratin antigens. Second report of the ISOBM TD 5-1 workshop
- Author
-
Nap, M, Andrés, L, Bishr Omary, M C, Bellanger, L, Bodenmuller, H, Bonfrer, H, Brundell, J, Einarsson, R, Erlandsson, Ann, Johansson, A, Leca, JF, Levi, M, Meir, T, Nustad, K, Seguin, P, Sjödin, A, Stigbrand, T, Sundström, Birgitta, van Dalen, A, Wioebelhaus, E, Wiklund, B, Ärl, Nap, M, Andrés, L, Bishr Omary, M C, Bellanger, L, Bodenmuller, H, Bonfrer, H, Brundell, J, Einarsson, R, Erlandsson, Ann, Johansson, A, Leca, JF, Levi, M, Meir, T, Nustad, K, Seguin, P, Sjödin, A, Stigbrand, T, Sundström, Birgitta, van Dalen, A, Wioebelhaus, E, Wiklund, B, and Ärl
- Published
- 2001
12. TO81 - L’impact de l’évaluation systématique de l’intensité de la douleur aiguë aux urgences
- Author
-
Hodaj, H., primary, Pellat, J., additional, Bellanger, L., additional, Kaddour, A., additional, Bourdat, C., additional, Jacquot, C., additional, and Alibeu, J., additional
- Published
- 2006
- Full Text
- View/download PDF
13. STATISTICAL ASPECTS OF POTTERY QUANTIFICATION FOR THE DATING OF SOME ARCHAEOLOGICAL CONTEXTS*
- Author
-
BELLANGER, L., primary, HUSI, PH., additional, and TOMASSONE, R., additional
- Published
- 2006
- Full Text
- View/download PDF
14. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens. The ISOBM TD5-1 Workshop
- Author
-
Stigbrand, T, Andrés, C, Bellanger, L, Bishr Omary, M, Bodenmüller, H, Bonfrer, H, Brundell, J, Einarsson, R, Erlandsson, Ann, Johansson, A, Leca, JF, Levi, M, Meier, T, Nap, M, Nustad, K, Seguin, P, Sjödin, A, Sundström, Birgitta, van Dahlen, A, Wiebelhaus, E, Wiklund, B, Ärlestig, L, Stigbrand, T, Andrés, C, Bellanger, L, Bishr Omary, M, Bodenmüller, H, Bonfrer, H, Brundell, J, Einarsson, R, Erlandsson, Ann, Johansson, A, Leca, JF, Levi, M, Meier, T, Nap, M, Nustad, K, Seguin, P, Sjödin, A, Sundström, Birgitta, van Dahlen, A, Wiebelhaus, E, Wiklund, B, and Ärlestig, L
- Published
- 1998
15. Immunohistochemical Profiles of 30 Monoclonal Antibodies against Cytokeratins 8, 18 and 19
- Author
-
Nap, M., primary, van Wel, Th., additional, Andrés, C., additional, Bellanger, L., additional, Bodenmüller, H., additional, Bonfrer, H., additional, Brundell, J., additional, Einarsson, R., additional, Erlandsson, A., additional, Johansson, A., additional, Leca, J.F., additional, Meier, T., additional, Seguin, P., additional, Sjödin, A., additional, Stigbrand, T., additional, Sundström, B.E., additional, van Dalen, A., additional, Wiebelhaus, E., additional, Wiklund, B., additional, and Hilgers, J., additional
- Published
- 2001
- Full Text
- View/download PDF
16. Summary Report of the TD-3 Workshop: Characterization of 83 Antibodies against Prostate-Specific Antigen
- Author
-
Stenman, U.-H., primary, Paus, E., additional, Allard, W.J., additional, Andersson, I., additional, Andrès, C., additional, Barnett, T.R., additional, Becker, C., additional, Belenky, A., additional, Bellanger, L., additional, Pellegrino, C.M., additional, Børmer, O.P., additional, Davis, G., additional, Dowell, B., additional, Grauer, L.S., additional, Jette, D.C., additional, Karlsson, B., additional, Kreutz, F.T., additional, van der Kwast, T.M., additional, Lauren, L., additional, Leinimaa, M., additional, Leinonen, J., additional, Lilja, H., additional, Linton, H.J., additional, Nap, M., additional, Nilsson, O., additional, Ng, P.C., additional, Nustad, K., additional, Peter, A., additional, Pettersson, K., additional, Piironen, T., additional, Rapp, J., additional, Rittenhouse, H.G., additional, Rye, P.D., additional, Seguin, P., additional, Slota, J., additional, Sokoloff, R.L., additional, Suresh, M.R., additional, Very, D.L., additional, Wang, T.J., additional, Wigheden, I., additional, Wolfert, R.L., additional, Yeung, K.K., additional, Zhang, W.-M., additional, Zhou, Z., additional, and Hilgers, J., additional
- Published
- 1999
- Full Text
- View/download PDF
17. Epitope Mapping of 53 Antibodies against Prostate-Specific Antigen
- Author
-
Bellanger, L., primary, Andrès, C., additional, and Seguin, P., additional
- Published
- 1999
- Full Text
- View/download PDF
18. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)
- Author
-
Degorce, F, primary, Goumon, Y, additional, Jacquemart, L, additional, Vidaud, C, additional, Bellanger, L, additional, Pons-Anicet, D, additional, Seguin, P, additional, Metz-Boutigue, M H, additional, and Aunis, D, additional
- Published
- 1998
- Full Text
- View/download PDF
19. Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 Workshop
- Author
-
Stigbrand (Chairman), T., primary, Andrés, C., additional, Bellanger, L., additional, Bishr Omary, M., additional, Bodenmüller, H., additional, Bonfrer, H., additional, Brundell, J., additional, Einarsson, R., additional, Erlandsson, A., additional, Johansson, A., additional, Leca, J.F., additional, Levi, M., additional, Meier, T., additional, Nap, M., additional, Nustad, K., additional, Seguin, P., additional, Sjödin, A., additional, Sundström, B., additional, van Dalen, A., additional, Wiebelhaus, E., additional, Wiklund, B., additional, Ärlestig, L., additional, and Hilgers (Coordinator), J., additional
- Published
- 1998
- Full Text
- View/download PDF
20. Comparison of a new microplate oestrogen receptor (ER) enzyme immunoassay with other ER detection methods
- Author
-
Delage, V, primary, Deytieux, S, additional, Le Doussal, V, additional, Degorce, F, additional, Bellanger, L, additional, Hacene, K, additional, Seguin, P, additional, Descotes, F, additional, Saez, S, additional, and Spyratos, F, additional
- Published
- 1997
- Full Text
- View/download PDF
21. Microtiter plate immunoenzymometric assay for estrogen receptor
- Author
-
Delage, V, primary, Teulon, J M, primary, Bellanger, L, primary, Seguin, P, primary, Descotes, F, primary, and Saez, S, primary
- Published
- 1996
- Full Text
- View/download PDF
22. 466 Free and α 1 antichymotrypsin bound PSA in prostate diseases
- Author
-
Guillet, J., primary, Role, C., additional, Pans, D., additional, Malard, V., additional, Bedeau, N., additional, Bellanger, L., additional, and Seguin, P., additional
- Published
- 1995
- Full Text
- View/download PDF
23. 1261 Clinical evaluation of specific assays for free PSA and total PSA
- Author
-
Bedeau, N., primary, Bellanger, L., additional, Malard, V., additional, Pons, D., additional, Seguin, P., additional, and Guillet, J., additional
- Published
- 1995
- Full Text
- View/download PDF
24. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).
- Author
-
Degorce, F, Goumon, Y, Jacquemart, L, Vidaud, C, Bellanger, L, Pons-Anicet, D, Seguin, P, Metz-Boutigue, M H, and Aunis, D
- Subjects
APOPTOSIS ,CHROMOGRANINS - Abstract
Chromogranin A (CgA), a major protein of chromaffin granules, has been described as a potential marker for neuroendocrine tumours. Because of an extensive proteolysis which leads to a large heterogeneity of circulating fragments, its presence in blood has been assessed in most cases either by competitive immunoassays or with polyclonal antibodies. In the present study, 24 monoclonal antibodies were raised against native or recombinant human CgA. Their mapping with proteolytic peptides showed that they defined eight distinct epitopic groups which spanned two-thirds of the C-terminal part of human CgA. All monoclonal antibodies were tested by pair and compared with a reference radioimmunoassay (RIA) involving CGS06, one of the monoclonal antibodies against the 198-245 sequence. It appears that CgA C-terminal end seems to be highly affected by proteolysis and the association of C-terminal and median-part monoclonal antibodies is inadequate for total CgA assessment. Our new immunoradiometric assay involves two monoclonal antibodies, whose contiguous epitopes lie within the median 145-245 sequence. This assay allows a sensitive detection of total human CgA and correlates well with RIA because dibasic cleavage sites present in the central domain do not seem to be affected by degradation. It has been proved to be efficient in measuring CgA levels in patients with neuroendocrine tumours. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
25. Engineering of a recombinant colorimetric fusion protein for immunodiagnosis of insulin
- Author
-
Chanussot, C., Bellanger, L., Ligny-Lemaire, C., Seguin, P., Menez, A., and Boulain, J.-C.
- Published
- 1996
- Full Text
- View/download PDF
26. Comparaison de méthodes de clusteringpour détecter des troubles de la marche à partir de données issues d’un capteur de mouvement
- Author
-
Drouin, P., Stamm, A., Chevreuil, L., Graillot, V., and Bellanger, L.
- Abstract
Les tests pour évaluer la dégradation de la marche des patients atteints de maladie neurodégénératives, comme la sclérose en plaques (SEP), consistent le plus souvent à mesurer le temps nécessaire au patient pour parcourir une distance fixée ou la distance qu’il peut parcourir en une certaine durée. Ces tests constituent une mesure peu précise et n’ont lieu que lors des consultations. L’utilisation d’objets connectés, tels que les capteurs de mouvement, pourrait permettre une mesure plus fréquente et plus précise de l’évolution de la maladie du patient, et ce aussi dans sa vie quotidienne. Dans le cadre d’un contrat de collaboration de recherche, l’entreprise UmanIT et le laboratoire de mathématiques Jean-Leray de Nantes développent une méthodologie statistique pour l’analyse des troubles de la marche à l’aide d’un capteur de mouvement placé à la ceinture. Une première version du dispositif a été développée et testée auprès de volontaires sains (employés d’UmanIT). L’objectif du travail présenté est de comparer les résultats de différentes méthodes de clusteringobtenus à partir de données issues du capteur de mouvement dans le but de construire des groupes d’individus possédant des cycles de marche similaires.
- Published
- 2020
- Full Text
- View/download PDF
27. Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19: Second report of the TD5 workshop
- Author
-
Nap, M., Wel, Th, Andrés, C., Bellanger, L., Bodenmüller, H., Bonfrer, H., Brundell, J., Einarsson, R., Ann Erlandsson, Johansson, A., Leca, J. F., Meier, T., Seguin, P., Sjödin, A., Stigbrand, T., Sundström, B. E., Dalen, A., Wiebelhaus, E., Wiklund, B., and Hilgers, J.
28. Design and characterization of near-native Ebola GP vaccine candidates: implications for immunogenicity
- Author
-
Agnolon, V, Ayadi, I, Bikorimana, J. P., Kiseljak, D., De Vaux, V., Wehrle, S., Correia, B., Gallais, F., Bellanger, L., Munoz-Fontela, C., Wurm, F., Corradin, G., and Spertini, F.
29. Étude de la désintégration 194Hg → 194Au
- Author
-
Bellanger, L., primary, Kilcher, P., additional, and Poffe, N., additional
- Published
- 1964
- Full Text
- View/download PDF
30. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations
- Author
-
Desnos-Ollivier, Marie, Bretagne, Stéphane, Lortholary, Olivier, Dromer, Françoise, French Mycoses Study Group, The, Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Laboratoire de Parasitologie-Mycologie [CHU Saint Louis, Paris], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre d'infectiologie Necker-Pasteur [CHU Necker], Institut Pasteur [Paris] (IP)-CHU Necker - Enfants Malades [AP-HP], Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), This work was supported by Santé Publique France and Institut Pasteur., Members of the French Mycoses Study Group who contributed to the data are, in alphabetical order of the cities, all the French microbiologists and mycologists who sent isolates for characterization of unusual antifungal susceptibility profiles or to contribute to the ongoing surveillance program on the epidemiology of invasive fungal infections in France (YEASTS and RESSIF programs): N. Brieu (CH Aix), T. Chouaki, C. Damiani, A. Totet (CHU Amiens), J. P. Bouchara, D. Chabasse, M. Pihet (CHU Angers), S. Bland (CH Annecy), V. Blanc (CH Antibes), S. Branger (CH Avignon), A. P. Bellanger, L. Millon (CHU Besançon), C. Plassart (CH Beauvais), I. Poilane (Hôpital Jean Verdier, Bondy), I. Accoceberry, L. Delhaes, B. Couprie, F. Gabriel (CH Bordeaux), J. Dunand, A. L. Roux, V. Sivadon-Tardy (Hôpital Ambroise Paré, Boulogne Billancourt), F. Laurent (CH, Bourg en Bresse), S. Legal, E. Moalic, G. Nevez, D. Quinio (CHU Brest), M. Cariou (CH Bretagne Sud), J. Bonhomme, C. Duhamel (CHU, Caen), B. Podac (CH, Chalon sur Saône), S. Lechatch (CH, Charleville-Mézières), C. Soler (Hopital d’Instruction des armées, Clamart), M. Cambon, C. Nourrisson, P. Poirier, D. Pons (CHU, Clermont Ferrand), O. Augereau, I. Grawey (CH, Colmar), N. Fauchet (CHIC, Créteil), A. Bonnin, F. Dalle (CHU, Dijon), P. Cahen, P. Honderlick (CMC, Foch), N. Desbois, C. Miossec (CHU, Fort de France), J. L. Hermann (Hôpital Raymond Poincaré, Garches), M. Cornet, R. Grillot, B. Lebeau, D. Maubon, H. Pelloux (CHU, Grenoble), M. Nicolas (CHU, Guadeloupe), C. Aznar, D. Blanchet, J. F. Carod, M. Demar, (CHU, Guyane), A. Angoulvant (Hôpital Bicêtre, le Kremlin Bicêtre), C. Ciupek (CH, Le Mans), A. Gigandon (Hôpital Marie Lannelongue, Le Plessis Robinson), B. Bouteille (CH Limoges), E. Frealle, D. Poulain, B. Sendid (CHU Lille), D. Dupont, J. Menotti, F. Persat, M.-A. Piens, M. Wallon (CHU, Lyon), C. Cassagne, S. Ranque (CHU, Marseille), T. Benoit-Cattin, L. Collet (CH Mayotte), A. Fiacre (CH Meaux), N. Bourgeois, L. Lachaud, P. Rispail, Y. Sterkers (CHU, Montpellier), M. Machouart (CHU, Nancy), F. Gay-Andrieu, P. Lepape, F. Morio (CHU, Nantes), O. Moquet (CH, Nevers), S. Lefrançois (Hôpital Américain, Neuilly), M. Sasso (CHU, Nimes), F. Reibel (GH, Nord-Essone), M. Gari-Toussaint, L. Hasseine (CHU Nice), L. Bret, D. Poisson (CHR Orléans), S. Brun (Hôpital Avicenne, Paris), C. Bonnal, C. Chochillon, S. Houzé (Hôpital Bichat, Paris), A. Paugam (Hôpital Cochin, Paris), N. Ait-Ammar, F. Botterel, R. Chouk (CHU Henri Mondor, Paris), M. E. Bougnoux, E. Sitterle (Hôpital Necker, Paris), A. Fekkar, R. Piarroux (Hôpital Pitié Salpêtrière, Paris), J. Guitard, C. Hennequin, J.-L. Poirot (Hôpital St Antoine, Paris), M. Gits-Muselli, S. Hamane, C. Lacroix (Hôpital Saint Louis, Paris), S. Bonacorsi, P. Mariani (Hôpital Robert Debré, Paris), D. Moissenet (Hôpital Trousseau, Paris), C. Kauffmann-Lacroix, A. Minoza, E. Perraud, M. H. Rodier (CHU Poitiers), G. Colonna (CH, Porto Vecchio), A. Huguenin, D. Toubas (CHU Reims), S. Chevrier, J. P. Gangneux, F. Robert-Gangneux, C. Guigen (CHU Rennes), O. Belmonte, G. Hoarau, M. C. Jaffar Bandjee, J. Jaubert, S. Picot, N. Traversier (CHU Réunion), L. Favennec, G. Gargala (CHU, Rouen), N. Godineau, C. Tournus (CH, St Denis), C. Mahinc, H. Raberin (CHU, St Etienne), V. Letscher Bru (CHU, Strasbourg), S. Cassaing (CHU, Toulouse), P. Patoz (CH Tourcoing), E. Bailly, J. Chandenier, G. Desoubeaux (CHU Tours), F. Moreau (CH Troyes), P. Munier (CH Valence), E. Mazars (CH Valenciennes), O. Eloy (CH Versailles), E. Chachaty (Institut Gustave Roussy, Villejuif), and and members of the NRCMA (Institut Pasteur, Paris): A. Bertho, C. Blanc, A. Boullié, C. Gautier, V. Geolier, D. Hoinard, and D. Raoux-Barbot for technical help, and K. Boukris-Sitbon, F. Lanternier, A. Alanio, and D. Garcia-Hermoso for their expertise and contribution to the surveillance programs.
- Subjects
Pharmacology ,Antifungal Agents ,[SDV]Life Sciences [q-bio] ,yeasts ,Microbial Sensitivity Tests ,antifungal resistance ,Anidulafungin ,bacterial infections and mycoses ,rare yeast ,common yeast ,Echinocandins ,Lipopeptides ,Infectious Diseases ,Susceptibility ,Caspofungin ,Drug Resistance, Fungal ,Mutation ,Micafungin ,polycyclic compounds ,FKS mutation ,Humans ,Candidiasis, Invasive ,Pharmacology (medical) ,MIC distribution - Abstract
International audience; Since echinocandins are recommended as first line therapy for invasive candidiasis, detection of resistance, mainly due to alteration in FKS protein, is of main interest. EUCAST AFST recommends testing both MIC of anidulafungin and micafungin, and breakpoints (BPs) have been proposed to detect echinocandin-resistant isolates. We analyzed MIC distribution for all three available echinocandins of 2,787 clinical yeast isolates corresponding to 5 common and 16 rare yeast species, using the standardized EUCAST method for anidulafungin and modified for caspofungin and micafungin (AM3-MIC). In our database, 64 isolates of common pathogenic species were resistant to anidulafungin, according to the EUCAST BP, and/or to caspofungin, using our previously published threshold (AM3-MIC ≥ 0.5 mg/L). Among these 64 isolates, 50 exhibited 21 different FKS mutations. We analyzed the capacity of caspofungin AM3-MIC and anidulafungin MIC determination in detecting isolates with FKS mutation. They were always identified using caspofungin AM3-MIC and the local threshold while some isolates were misclassified using anidulafungin MIC and EUCAST threshold. However, both methods misclassified four wild-type C. glabrata as resistant. Based on a large data set from a single center, the use of AM3-MIC testing for caspofungin looks promising in identifying non-wild-type C. albicans, C. tropicalis and P. kudiravzevii isolates, but additional multicenter comparison is mandatory to conclude on the possible superiority of AM3-MIC testing compared to the EUCAST method.
- Published
- 2022
- Full Text
- View/download PDF
31. Azoles susceptibility profiles of more than 9,000 clinical yeast isolates belonging to 40 common and rare species
- Author
-
Olivier Lortholary, Françoise Dromer, Stéphane Bretagne, Marie Desnos-Ollivier, Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Service des Maladies infectieuses et tropicales [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Parasitologie-Mycologie [CHU Saint Louis, Paris], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Université Paris Cité (UPCité), Institut Pasteur and Santé Publique France., Members of the French Mycoses Study group who contributed to the data are in alphabetical order of the cities, all the French microbiologists and mycologists who sent isolates for characterization of unusual antifungal susceptibility profiles or to contribute to the ongoing surveillance program on the epidemiology of invasive fungal infections in France (YEASTS and RESSIF programs): N. Brieu (CH Aix), T. Chouaki, C. Damiani, A. Totet (CHU Amiens, J. P. Bouchara, M. Pihet (CHU Angers), S. Bland (CH Annecy), V. Blanc (CH Antibes), S. Branger (CH Avignon), A. P. Bellanger, L. Million (CHU Besançon), C. Plassart (CH Beauvais), I. Poilane (hôpital Jean Verdier, Bondy), I. Accoceberry, L. Delhaes, F. Gabriel (CH Bordeaux), A. L. Roux, V. Sivadon-Tardy (hôpital Ambroise Paré, Boulogne Billancourt), F. Laurent (CH, Bourg en Bresse), S. Legal, E. Moalic, G. Nevez, D. Quinio (CHU Brest), M. Cariou (CH Bretagne Sud), J. Bonhomme (CHU, Caen), B. Podac (CH, Chalon sur Saône), S. Lechatch (CH, Charleville-Mézières), C. Soler (hopital d’Instruction des armées, Clamart), P. Poirier, C. Nourrisson (CHU, Clermont Ferrand), O. Augereau (CH, Colmar), N. Fauchet (CHIC, Créteil), F. Dalles (CHU, Dijon), P. Cahen (CMC, Foch), N. Desbois, C. Miossec (CHU, Fort de France), J. L. Hermann (hôpital Raymond Poincaré, Garches), M. Cornet, D. Maubon, H. Pelloux (CHU, Grenoble), M. Nicolas (CHU,Guadeloupe), C. Aznar, D. Blanchet, J. F. Carod, M. Demar, (CHU, Guyane), A. Angoulvant (hôpital Bicêtre, le Kremlin Bicêtre), C. Ciupek (CH, Le Mans), A. Gigandon (hôpital Marie Lannelongue, Le Plessis Robinson), B. Bouteille (CH Limoges), E. Frealle, B. Sendid (CHU Lille), D. Dupont, J. Menotti, F. Persat, M. Wallon (CHU, Lyon), C. Cassagne, S. Ranque (CHU, Marseille), T. Benoit-Cattin, L. Collet (CH Mayotte), A. Fiacre (CH Meaux), N. Bourgeois, L. Lachaud (CHU, Montpellier), M. Machouart (CHU, Nancy), P. Lepape, F. Morio (CHU, Nantes), O. Moquet (CH, Nevers), S. Lefrançois (hôpital Américain, Neuilly), M. Sasso (CHU, Nimes), F. Reibel (GH, Nord-Essone), M. Gari-Toussaint, L. Hasseine (CHU Nice), L. Bret, D. Poisson (CHR Orléans), S. Brun (hôpital Avicenne, Paris), C. Bonnal, S. Houze (hôpital Bichat, Paris), A. Paugam (hôpital Cochin, Paris), E. Dannaoui (HEGP, Paris), N. Ait-Ammar, F. Botterel, R. Chouk (CHU Henri Mondor, Paris), M. E. Bougnoux, E. Sitterle (hôpital Necker, Paris), A. Fekkar, R. Piarroux (hôpital Pitié Salpêtrière, Paris), J. Guitard, C. Hennequin (hôpital St Antoine, Paris), M. Gits-Muselli, S. Hamane (hôpital Saint Louis, Paris), S. Bonacorsi, P. Mariani (hôpital Robert Debré, Paris), D. Moissenet (hôpital Trousseau, Paris), A. Minoza, E. Perraud, M. H. Rodier (CHU Poitiers), G. Colonna (CH, Porto Vecchio), D. Toubas (CHU Reims), J. P. Gangneux, F. Robert-Gangneux (CHU Rennes), O. Belmonte, G. Hoarau, M. C. Jaffar Bandjee, J. Jaubert, S. Picot, N. Traversier (CHU Réunion), L. Favennec, G. Gargala (CHU, Rouen), C. Tournus (CH, St Denis), H. Raberin (CHU, St Etienne), V. Letscher Bru (CHU, Strasbourg), S. Cassaing (CHU, Toulouse), P. Patoz (CH Tourcoing), E. Bailly, G. Desoubeaux (CHU Tours), F. Moreau (CH Troyes), P. Munier (CH Valence), E. Mazars (CH Valenciennes), O. Eloy (CH Versailles), E. Chachaty (Institut Gustave Roussy, Villejuif), and members of the NRCMA (Institut Pasteur, Paris): A. Boullié, C. Gautier, V. Geolier, C. Blanc, D. Hoinard and D. Raoux-Barbot for technical help, and K. Boukris-Sitbon, F. Lanternier, A. Alanio, D. Garcia-Hermoso for their expertise and contribution to the surveillance programs., Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], and Université de Paris (UP)
- Subjects
Serotype ,Azoles ,Antifungal Agents ,Microbial Sensitivity Tests ,Candida parapsilosis ,Rhodotorula mucilaginosa ,Pichia ,Microbiology ,Candida tropicalis ,03 medical and health sciences ,0302 clinical medicine ,Drug Resistance, Fungal ,Pharmacology (medical) ,030212 general & internal medicine ,Candida albicans ,[SDV.MP.MYC]Life Sciences [q-bio]/Microbiology and Parasitology/Mycology ,Pharmacology ,chemistry.chemical_classification ,0303 health sciences ,biology ,Candida glabrata ,030306 microbiology ,Broth microdilution ,Rhodotorula ,biology.organism_classification ,3. Good health ,Infectious Diseases ,chemistry ,Susceptibility ,Saccharomycetales ,Azole ,France - Abstract
Invasive yeast infections represent a major global public health issue, and only few antifungal agents are available. Azoles are one of the classes of antifungals used for treatment of invasive candidiasis. The determination of antifungal susceptibility profiles using standardized methods is important to identify resistant isolates and to uncover the potential emergence of intrinsically resistant species. Here, we report data on 9,319 clinical isolates belonging to 40 pathogenic yeast species recovered in France over 17 years. The antifungal susceptibility profiles were all determined at the National Reference Center for Invasive Mycoses and Antifungals based on the EUCAST broth microdilution method. The centralized collection and analysis allowed us to describe the trends of azole susceptibility of isolates belonging to common species, confirming the high susceptibility for Candida albicans (n = 3,295), Candida tropicalis (n = 641), and Candida parapsilosis (n = 820) and decreased susceptibility for Candida glabrata (n = 1,274) and Pichia kudriavzevii (n = 343). These profiles also provide interesting data concerning azole susceptibility of Cryptococcus neoformans species complex, showing comparable MIC distributions for the three species but lower MIC(50)s and MIC(90)s for serotype D (n = 208) compared to serotype A (n = 949) and AD hybrids (n = 177). Finally, these data provide useful information for rare and/or emerging species, such as Clavispora lusitaniae (n = 221), Saprochaete clavata (n = 184), Meyerozyma guilliermondii complex (n = 150), Candida haemulonii complex (n = 87), Rhodotorula mucilaginosa (n = 55), and Wickerhamomyces anomalus (n = 36).
- Published
- 2021
- Full Text
- View/download PDF
32. Universal Identification of Pathogenic Viruses by Liquid Chromatography Coupled with Tandem Mass Spectrometry Proteotyping.
- Author
-
Lozano C, Pible O, Eschlimann M, Giraud M, Debroas S, Gaillard JC, Bellanger L, Taysse L, and Armengaud J
- Subjects
- Chromatography, Liquid methods, Humans, Viruses isolation & purification, Viruses classification, Saliva virology, Feces virology, Vaccinia virus isolation & purification, Tandem Mass Spectrometry methods, Proteomics methods
- Abstract
Accurate and rapid identification of viruses is crucial for an effective medical diagnosis when dealing with infections. Conventional methods, including DNA amplification techniques or lateral-flow assays, are constrained to a specific set of targets to search for. In this study, we introduce a novel tandem mass spectrometry proteotyping-based method that offers a universal approach for the identification of pathogenic viruses and other components, eliminating the need for a priori knowledge of the sample composition. Our protocol relies on a time and cost-efficient peptide sample preparation, followed by an analysis with liquid chromatography coupled to high-resolution tandem mass spectrometry. As a proof of concept, we first assessed our method on publicly available shotgun proteomics datasets obtained from virus preparations and fecal samples of infected individuals. Successful virus identification was achieved with 53 public datasets, spanning 23 distinct viral species. Furthermore, we illustrated the method's capability to discriminate closely related viruses within the same sample, using alphaviruses as an example. The clinical applicability of our method was demonstrated by the accurate detection of the vaccinia virus in spiked saliva, a matrix of paramount clinical significance due to its non-invasive and easily obtainable nature. This innovative approach represents a significant advancement in pathogen detection and paves the way for enhanced diagnostic capabilities., Competing Interests: Conflict of interest The authors declare no conflicts of interest with the contents of this article., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
33. The genome and population genomics of allopolyploid Coffea arabica reveal the diversification history of modern coffee cultivars.
- Author
-
Salojärvi J, Rambani A, Yu Z, Guyot R, Strickler S, Lepelley M, Wang C, Rajaraman S, Rastas P, Zheng C, Muñoz DS, Meidanis J, Paschoal AR, Bawin Y, Krabbenhoft TJ, Wang ZQ, Fleck SJ, Aussel R, Bellanger L, Charpagne A, Fournier C, Kassam M, Lefebvre G, Métairon S, Moine D, Rigoreau M, Stolte J, Hamon P, Couturon E, Tranchant-Dubreuil C, Mukherjee M, Lan T, Engelhardt J, Stadler P, Correia De Lemos SM, Suzuki SI, Sumirat U, Wai CM, Dauchot N, Orozco-Arias S, Garavito A, Kiwuka C, Musoli P, Nalukenge A, Guichoux E, Reinout H, Smit M, Carretero-Paulet L, Filho OG, Braghini MT, Padilha L, Sera GH, Ruttink T, Henry R, Marraccini P, Van de Peer Y, Andrade A, Domingues D, Giuliano G, Mueller L, Pereira LF, Plaisance S, Poncet V, Rombauts S, Sankoff D, Albert VA, Crouzillat D, de Kochko A, and Descombes P
- Subjects
- Coffee, Genome, Plant genetics, Metagenomics, Plant Breeding, Coffea genetics
- Abstract
Coffea arabica, an allotetraploid hybrid of Coffea eugenioides and Coffea canephora, is the source of approximately 60% of coffee products worldwide, and its cultivated accessions have undergone several population bottlenecks. We present chromosome-level assemblies of a di-haploid C. arabica accession and modern representatives of its diploid progenitors, C. eugenioides and C. canephora. The three species exhibit largely conserved genome structures between diploid parents and descendant subgenomes, with no obvious global subgenome dominance. We find evidence for a founding polyploidy event 350,000-610,000 years ago, followed by several pre-domestication bottlenecks, resulting in narrow genetic variation. A split between wild accessions and cultivar progenitors occurred ~30.5 thousand years ago, followed by a period of migration between the two populations. Analysis of modern varieties, including lines historically introgressed with C. canephora, highlights their breeding histories and loci that may contribute to pathogen resistance, laying the groundwork for future genomics-based breeding of C. arabica., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
34. Smoothing method for unit quaternion time series in a classification problem: an application to motion data.
- Author
-
Ballante E, Bellanger L, Drouin P, Figini S, and Stamm A
- Subjects
- Time Factors, Motion, Algorithms
- Abstract
Smoothing orientation data is a fundamental task in different fields of research. Different methods of smoothing time series in quaternion algebras have been described in the literature, but their application is still an open point. This paper develops a smoothing approach for smoothing quaternion time series to obtain good performance in classification problems. Starting from an existing method which involves an angular velocity transformation of unit quaternion time series, a new method which employ the logarithm function to transform the quaternion time series to a real three-dimensional time series is proposed. Empirical evidences achieved on real data set and artificially noisy data sets confirm the effectiveness of the proposed method compared with the classical approach based on angular velocity transformation. The R functions developed for this paper will be provided in a Github repository., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
35. Semi-supervised clustering of quaternion time series: Application to gait analysis in multiple sclerosis using motion sensor data.
- Author
-
Drouin P, Stamm A, Chevreuil L, Graillot V, Barbin L, Gourraud PA, Laplaud DA, and Bellanger L
- Subjects
- Humans, Time Factors, Gait, Walking, Gait Analysis, Multiple Sclerosis
- Abstract
Recent approaches in gait analysis involve the use of wearable motion sensors to extract spatio-temporal parameters that characterize multiple aspects of an individual's gait. In particular, the medical community could largely benefit from this type of devices as they could provide the clinicians with a valuable tool for assessing gait impairment. Motion sensor data are however complex and there is an urgent unmet need to develop sound statistical methods for analyzing such data and extracting clinically relevant information. In this article, we measure gait by following the hip rotation over time and the resulting statistical unit is a time series of unit quaternions. We explore the possibility to form groups of patients with similar walking impairment by taking into account their walking data and their global decease severity with semi-supervised clustering. We generalize a compromise-based method named hclustcompro to unit quaternion time series by combining it with the proper dissimilarity quaternion dynamic time warping. We apply this method on patients diagnosed with multiple sclerosis to form groups of patients with similar walking deficiencies while accounting for the clinical assessment of their overall disability. We also compare the compromise-based clustering approach with the method mergeTrees that falls into a sub-class of ensemble clustering named collaborative clustering. The results provide a first proof of both the interest of using wearable motion sensors for assessing gait impairment and the use of prior knowledge to guide the clustering process. It also demonstrates that compromise-based clustering is a more appropriate approach in this context., (© 2022 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
36. Mass spectrometry detection of monkeypox virus: Comprehensive coverage for ranking the most responsive peptide markers.
- Author
-
Lozano C, Grenga L, Gallais F, Miotello G, Bellanger L, and Armengaud J
- Subjects
- Humans, Mass Spectrometry methods, Peptides analysis, Proteome, Proteomics methods, Viral Proteins chemistry, Monkeypox virus isolation & purification, Mpox (monkeypox) diagnosis
- Abstract
The recent and sudden outbreak of monkeypox in numerous non-endemic countries requires expanding its surveillance immediately and understanding its origin and spread. As learned from the COVID-19 pandemic, appropriate detection techniques are crucial to achieving such a goal. Mass spectrometry has the advantages of a rapid response, low analytical interferences, better precision, and easier multiplexing to detect various pathogens and their variants. In this proteomic dataset, we report experimental data on the proteome of the monkeypox virus (MPXV) recorded by state-of-the-art shotgun proteomics, including data-dependent and data-independent acquisition for comprehensive coverage. We highlighted 152 viral proteins, corresponding to an overall proteome coverage of 79.5 %. Among the 1371 viral peptides detected, 35 peptides with the most intense signals in mass spectrometry were selected, representing a subset of 13 viral proteins. Their relevance as potential candidate markers for virus detection by targeted mass spectrometry is discussed. This report should assist the rapid development of mass spectrometry-based tests to detect a pathogen of increasing concern., (© 2022 Wiley-VCH GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
37. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
- Author
-
Grenga L, Pible O, Miotello G, Culotta K, Ruat S, Roncato MA, Gas F, Bellanger L, Claret PG, Dunyach-Remy C, Laureillard D, Sotto A, Lavigne JP, and Armengaud J
- Subjects
- Dysbiosis, Feces, Humans, RNA, Viral genetics, SARS-CoV-2 genetics, COVID-19, Microbiota genetics
- Abstract
Since the beginning of the pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the gastrointestinal (GI) tract has emerged as an important organ influencing the propensity to and potentially the severity of the related COVID-19 disease. However, the contribution of the SARS-CoV-2 intestinal infection on COVID-19 pathogenesis remains to be clarified. In this exploratory study, we highlighted a possible link between alterations in the composition of the gut microbiota and the levels of SARS-CoV-2 RNA in the gastrointestinal tract, which could be more important than the presence of SARS-CoV-2 in the respiratory tract, COVID-19 severity and GI symptoms. As established by metaproteomics, altered molecular functions in the microbiota profiles of high SARS-CoV-2 RNA level faeces highlight mechanisms such as inflammation-induced enterocyte damage, increased intestinal permeability and activation of immune response that may contribute to vicious cycles. Uncovering the role of this gut microbiota dysbiosis could drive the investigation of alternative therapeutic strategies to favour the clearance of the virus and potentially mitigate the effect of the SARS-CoV-2 infection., (© 2022 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
38. A Novel Walking Activity Recognition Model for Rotation Time Series Collected by a Wearable Sensor in a Free-Living Environment.
- Author
-
Brard R, Bellanger L, Chevreuil L, Doistau F, Drouin P, and Stamm A
- Subjects
- Gait, Rotation, Time Factors, Walking, Wearable Electronic Devices
- Abstract
Solutions to assess walking deficiencies are widespread and largely used in healthcare. Wearable sensors are particularly appealing, as they offer the possibility to monitor gait in everyday life, outside a facility in which the context of evaluation biases the measure. While some wearable sensors are powerful enough to integrate complex walking activity recognition models, non-invasive lightweight sensors do not always have the computing or memory capacity to run them. In this paper, we propose a walking activity recognition model that offers a viable solution to this problem for any wearable sensors that measure rotational motion of body parts. Specifically, the model was trained and tuned using data collected by a motion sensor in the form of a unit quaternion time series recording the hip rotation over time. This time series was then transformed into a real-valued time series of geodesic distances between consecutive quaternions. Moving average and moving standard deviation versions of this time series were fed to standard machine learning classification algorithms. To compare the different models, we used metrics to assess classification performance (precision and accuracy) while maintaining the detection prevalence at the level of the prevalence of walking activities in the data, as well as metrics to assess change point detection capability and computation time. Our results suggest that the walking activity recognition model with a decision tree classifier yields the best compromise in terms of precision and computation time. The sensor that was used had purposely low computing and memory capacity so that reported performances can be thought of as the lower bounds of what can be achieved. Walking activity recognition is performed online, i.e., on-the-fly, which further extends the range of applicability of our model to sensors with very low memory capacity.
- Published
- 2022
- Full Text
- View/download PDF
39. Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift.
- Author
-
Laroche A, Orsini Delgado ML, Chalopin B, Cuniasse P, Dubois S, Sierocki R, Gallais F, Debroas S, Bellanger L, Simon S, Maillère B, and Nozach H
- Subjects
- Antibodies, Neutralizing, Antibodies, Viral, Antigenic Drift and Shift, Humans, Protein Binding, SARS-CoV-2 genetics, Spike Glycoprotein, Coronavirus genetics, COVID-19, Single-Domain Antibodies
- Abstract
Here, we report the molecular engineering of nanobodies that bind with picomolar affinity to both SARS-CoV-1 and SARS-CoV-2 receptor-binding domains (RBD) and are highly neutralizing. We applied deep mutational engineering to VHH72, a nanobody initially specific for SARS-CoV-1 RBD with little cross-reactivity to SARS-CoV-2 antigen. We first identified all the individual VHH substitutions that increase binding to SARS-CoV-2 RBD and then screened highly focused combinatorial libraries to isolate engineered nanobodies with improved properties. The corresponding VHH-Fc molecules show high affinities for SARS-CoV-2 antigens from various emerging variants and SARS-CoV-1, block the interaction between ACE2 and RBD, and neutralize the virus with high efficiency. Its rare specificity across sarbecovirus relies on its peculiar epitope outside the immunodominant regions. The engineered nanobodies share a common motif of three amino acids, which contribute to the broad specificity of recognition. Our results show that deep mutational engineering is a very powerful method, especially to rapidly adapt existing antibodies to new variants of pathogens.
- Published
- 2022
- Full Text
- View/download PDF
40. Heterogeneity of SARS-CoV-2 virus produced in cell culture revealed by shotgun proteomics and supported by genome sequencing.
- Author
-
Gallais F, Pible O, Gaillard JC, Debroas S, Batina H, Ruat S, Sandron F, Delafoy D, Gerber Z, Olaso R, Gas F, Bellanger L, Deleuze JF, Grenga L, and Armengaud J
- Subjects
- Amino Acid Sequence, Cell Culture Techniques, Humans, Real-Time Polymerase Chain Reaction methods, SARS-CoV-2 genetics, SARS-CoV-2 pathogenicity, Tandem Mass Spectrometry methods, Viral Proteins chemistry, Virulence, Genome, Viral, Proteomics methods, SARS-CoV-2 isolation & purification
- Abstract
COVID-19 is the most disturbing pandemic of the past hundred years. Its causative agent, the SARS-CoV-2 virus, has been the subject of an unprecedented investigation to characterize its molecular structure and intimate functioning. While markers for its detection have been proposed and several diagnostic methodologies developed, its propensity to evolve and evade diagnostic tools and the immune response is of great concern. The recent spread of new variants with increased infectivity requires even more attention. Here, we document how shotgun proteomics can be useful for rapidly monitoring the evolution of the SARS-CoV-2 virus. We evaluated the heterogeneity of purified SARS-CoV-2 virus obtained after culturing in the Vero E6 cell line. We found that cell culture induces significant changes that are translated at the protein level, such changes being detectable by tandem mass spectrometry. Production of viral particles requires careful quality control which can be easily performed by shotgun proteomics. Although considered relatively stable so far, the SARS-CoV-2 genome turns out to be prone to frequent variations. Therefore, the sequencing of SARS-CoV-2 variants from patients reporting only the consensus genome after its amplification would deserve more attention and could benefit from more in-depth analysis of low level but crystal-clear signals, as well as complementary and rapid analysis by shotgun proteomics., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
41. The absence of the caffeine synthase gene is involved in the naturally decaffeinated status of Coffea humblotiana, a wild species from Comoro archipelago.
- Author
-
Raharimalala N, Rombauts S, McCarthy A, Garavito A, Orozco-Arias S, Bellanger L, Morales-Correa AY, Froger S, Michaux S, Berry V, Metairon S, Fournier C, Lepelley M, Mueller L, Couturon E, Hamon P, Rakotomalala JJ, Descombes P, Guyot R, and Crouzillat D
- Subjects
- Amino Acid Sequence, Caffeine analysis, Chromosomes, Plant, Coffea chemistry, Coffea enzymology, Comoros, Comparative Genomic Hybridization, Evolution, Molecular, Methyltransferases classification, Methyltransferases deficiency, Phylogeny, Plant Leaves chemistry, Plant Leaves enzymology, Plant Leaves genetics, Plant Proteins classification, Plant Proteins metabolism, Sequence Alignment, Sequence Analysis, RNA, Theobromine analysis, Coffea genetics, Methyltransferases genetics, Plant Proteins genetics
- Abstract
Caffeine is the most consumed alkaloid stimulant in the world. It is synthesized through the activity of three known N-methyltransferase proteins. Here we are reporting on the 422-Mb chromosome-level assembly of the Coffea humblotiana genome, a wild and endangered, naturally caffeine-free, species from the Comoro archipelago. We predicted 32,874 genes and anchored 88.7% of the sequence onto the 11 chromosomes. Comparative analyses with the African Robusta coffee genome (C. canephora) revealed an extensive genome conservation, despite an estimated 11 million years of divergence and a broad diversity of genome sizes within the Coffea genus. In this genome, the absence of caffeine is likely due to the absence of the caffeine synthase gene which converts theobromine into caffeine through an illegitimate recombination mechanism. These findings pave the way for further characterization of caffeine-free species in the Coffea genus and will guide research towards naturally-decaffeinated coffee drinks for consumers.
- Published
- 2021
- Full Text
- View/download PDF
42. Genetic diversity of native and cultivated Ugandan Robusta coffee (Coffea canephora Pierre ex A. Froehner): Climate influences, breeding potential and diversity conservation.
- Author
-
Kiwuka C, Goudsmit E, Tournebize R, de Aquino SO, Douma JC, Bellanger L, Crouzillat D, Stoffelen P, Sumirat U, Legnaté H, Marraccini P, de Kochko A, Andrade AC, Mulumba JW, Musoli P, Anten NPR, and Poncet V
- Subjects
- Climate, Coffea genetics, Coffea growth & development, Conservation of Natural Resources, Genetic Variation, Plant Breeding
- Abstract
Wild genetic resources and their ability to adapt to environmental change are critically important in light of the projected climate change, while constituting the foundation of agricultural sustainability. To address the expected negative effects of climate change on Robusta coffee trees (Coffea canephora), collecting missions were conducted to explore its current native distribution in Uganda over a broad climatic range. Wild material from seven forests could thus be collected. We used 19 microsatellite (SSR) markers to assess genetic diversity and structure of this material as well as material from two ex-situ collections and a feral population. The Ugandan C. canephora diversity was then positioned relative to the species' global diversity structure. Twenty-two climatic variables were used to explore variations in climatic zones across the sampled forests. Overall, Uganda's native C. canephora diversity differs from other known genetic groups of this species. In northwestern (NW) Uganda, four distinct genetic clusters were distinguished being from Zoka, Budongo, Itwara and Kibale forests A large southern-central (SC) cluster included Malabigambo, Mabira, and Kalangala forest accessions, as well as feral and cultivated accessions, suggesting similarity in genetic origin and strong gene flow between wild and cultivated compartments. We also confirmed the introduction of Congolese varieties into the SC region where most Robusta coffee production takes place. Identified populations occurred in divergent environmental conditions and 12 environmental variables significantly explained 16.3% of the total allelic variation across populations. The substantial genetic variation within and between Ugandan populations with different climatic envelopes might contain adaptive diversity to cope with climate change. The accessions that we collected have substantially enriched the diversity hosted in the Ugandan collections and thus contribute to ex situ conservation of this vital genetic resource. However, there is an urgent need to develop strategies to enhance complementary in-situ conservation of Coffea canephora in native forests in northwestern Uganda., Competing Interests: DC and LB are employed by Nestlé Centre Tours. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
- Published
- 2021
- Full Text
- View/download PDF
43. Quantitative Assessment of SARS-CoV-2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins.
- Author
-
Saadi J, Oueslati S, Bellanger L, Gallais F, Dortet L, Roque-Afonso AM, Junot C, Naas T, Fenaille F, and Becher F
- Subjects
- COVID-19 virology, Culture Media, Humans, Nucleocapsid metabolism, Proteomics methods, Reproducibility of Results, SARS-CoV-2 physiology, Sensitivity and Specificity, Specimen Handling instrumentation, Specimen Handling methods, Viral Proteins metabolism, COVID-19 diagnosis, Chromatography, Liquid methods, Nasopharynx virology, SARS-CoV-2 metabolism, Spike Glycoprotein, Coronavirus metabolism, Tandem Mass Spectrometry methods
- Abstract
Alternative methods to RT-PCR for SARS-CoV-2 detection are investigated to provide complementary data on viral proteins, increase the number of tests performed, or identify false positive/negative results. Here, we have developed a simple mass spectrometry assay for SARS-CoV-2 in nasopharyngeal swab samples using common laboratory reagents. The method employs high sensitivity and selectivity targeted mass spectrometry detection, monitoring nine constitutive peptides representative of the three main viral proteins and a straightforward pellet digestion protocol for convenient routine applications. Absolute quantification of N, M, and S proteins was achieved by addition of isotope-labeled versions of best peptides. Limit of detection, recovery, precision, and linearity were thoroughly evaluated in four representative viral transport media (VTM) containing distinct total protein content. The protocol was sensitive in all swab media with limit of detection determined at 2 × 10
3 pfu/mL, corresponding to as low as 30 pfu injected into the LC-MS/MS system. When tested on VTM-stored nasopharyngeal swab samples from positive and control patients, sensitivity was similar to or better than rapid immunoassay dipsticks, revealing a corresponding RT-PCR detection threshold at Ct ∼ 24. The study represents the first thorough evaluation of sensitivity and robustness of targeted mass spectrometry in nasal swabs, constituting a promising SARS-CoV-2 antigen assay for the first-line diagnosis of COVID-19 and compatible with the constraints of clinical settings. The raw files generated in this study can be found on PASSEL (Peptide Atlas) under data set identifier PASS01646.- Published
- 2021
- Full Text
- View/download PDF
44. Location of intracranial aneurysms is the main factor associated with rupture in the ICAN population.
- Author
-
Rousseau O, Karakachoff M, Gaignard A, Bellanger L, Bijlenga P, Constant Dit Beaufils P, L'Allinec V, Levrier O, Aguettaz P, Desilles JP, Michelozzi C, Marnat G, Vion AC, Loirand G, Desal H, Redon R, Gourraud PA, and Bourcier R
- Subjects
- Age Factors, Aged, Algorithms, Aneurysm, Ruptured prevention & control, Female, Humans, Intracranial Aneurysm diagnostic imaging, Intracranial Aneurysm pathology, Machine Learning, Magnetic Resonance Imaging, Male, Middle Aged, Neuroimaging, Risk Factors, Tomography, X-Ray Computed, Aneurysm, Ruptured etiology, Intracranial Aneurysm complications
- Abstract
Background and Purpose: The ever-growing availability of imaging led to increasing incidentally discovered unruptured intracranial aneurysms (UIAs). We leveraged machine-learning techniques and advanced statistical methods to provide new insights into rupture intracranial aneurysm (RIA) risks., Methods: We analysed the characteristics of 2505 patients with intracranial aneurysms (IA) discovered between 2016 and 2019. Baseline characteristics, familial history of IA, tobacco and alcohol consumption, pharmacological treatments before the IA diagnosis, cardiovascular risk factors and comorbidities, headaches, allergy and atopy, IA location, absolute IA size and adjusted size ratio (aSR) were analysed with a multivariable logistic regression (MLR) model. A random forest (RF) method globally assessed the risk factors and evaluated the predictive capacity of a multivariate model., Results: Among 994 patients with RIA (39.7%) and 1511 patients with UIA (60.3 %), the MLR showed that IA location appeared to be the most significant factor associated with RIA (OR, 95% CI: internal carotid artery, reference; middle cerebral artery, 2.72, 2.02-3.58; anterior cerebral artery, 4.99, 3.61-6.92; posterior circulation arteries, 6.05, 4.41-8.33). Size and aSR were not significant factors associated with RIA in the MLR model and antiplatelet-treatment intake patients were less likely to have RIA (OR: 0.74; 95% CI: 0.55-0.98). IA location, age, following by aSR were the best predictors of RIA using the RF model., Conclusions: The location of IA is the most consistent parameter associated with RIA. The use of 'artificial intelligence' RF helps to re-evaluate the contribution and selection of each risk factor in the multivariate model., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
45. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines.
- Author
-
Grenga L, Gallais F, Pible O, Gaillard JC, Gouveia D, Batina H, Bazaline N, Ruat S, Culotta K, Miotello G, Debroas S, Roncato MA, Steinmetz G, Foissard C, Desplan A, Alpha-Bazin B, Almunia C, Gas F, Bellanger L, and Armengaud J
- Subjects
- Animals, Antigens, Viral immunology, Chlorocebus aethiops, SARS-CoV-2, Tandem Mass Spectrometry, Vero Cells, Antigens, Viral biosynthesis, Betacoronavirus immunology, Proteomics methods, Viral Vaccines immunology, Virion immunology
- Abstract
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic and is continuing to spread rapidly around the globe. No effective vaccine is currently available to prevent COVID-19, and intense efforts are being invested worldwide into vaccine development. In this context, all technology platforms must overcome several challenges resulting from the use of an incompletely characterized new virus. These include finding the right conditions for virus amplification for the development of vaccines based on inactivated or attenuated whole viral particles. Here, we describe a shotgun tandem mass spectrometry workflow, the data produced can be used to guide optimization of the conditions for viral amplification. In parallel, we analysed the changes occurring in the host cell proteome following SARS-CoV-2 infection to glean information on the biological processes modulated by the virus that could be further explored as potential drug targets to deal with the pandemic.
- Published
- 2020
- Full Text
- View/download PDF
46. Proteotyping SARS-CoV-2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window.
- Author
-
Gouveia D, Miotello G, Gallais F, Gaillard JC, Debroas S, Bellanger L, Lavigne JP, Sotto A, Grenga L, Pible O, and Armengaud J
- Subjects
- COVID-19, COVID-19 Testing, Chromatography, Liquid, Coronavirus Nucleocapsid Proteins, Humans, Nucleocapsid Proteins chemistry, Phosphoproteins, SARS-CoV-2, Betacoronavirus chemistry, Clinical Laboratory Techniques methods, Coronavirus Infections diagnosis, Coronavirus Infections virology, Nasopharynx virology, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral virology, Tandem Mass Spectrometry methods
- Abstract
Rapid but yet sensitive, specific, and high-throughput detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical samples is key to diagnose infected people and to better control the spread of the virus. Alternative methodologies to PCR and immunodiagnostics that would not require specific reagents are worthy to investigate not only for fighting the COVID-19 pandemic but also to detect other emergent pathogenic threats. Here, we propose the use of tandem mass spectrometry to detect SARS-CoV-2 marker peptides in nasopharyngeal swabs. We documented that the signal from the microbiota present in such samples is low and can be overlooked when interpreting shotgun proteomic data acquired on a restricted window of the peptidome landscape. In this proof-of-concept study, simili nasopharyngeal swabs spiked with different quantities of purified SARS-CoV-2 viral material were used to develop a nanoLC-MS/MS acquisition method, which was then successfully applied on COVID-19 clinical samples. We argue that peptides ADETQALPQR and GFYAQGSR from the nucleocapsid protein are of utmost interest as their signal is intense and their elution can be obtained within a 3 min window in the tested conditions. These results pave the way for the development of time-efficient viral diagnostic tests based on mass spectrometry.
- Published
- 2020
- Full Text
- View/download PDF
47. Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity.
- Author
-
Agnolon V, Kiseljak D, Wurm MJ, Wurm FM, Foissard C, Gallais F, Wehrle S, Muñoz-Fontela C, Bellanger L, Correia BE, Corradin G, and Spertini F
- Subjects
- Animals, CHO Cells, Cricetulus, Humans, Mice, Antibodies, Neutralizing immunology, Antibodies, Viral immunology, Ebola Vaccines immunology, Vaccines, Subunit immunology, Viral Envelope Proteins immunology
- Abstract
The humoral responses of Ebola virus (EBOV) survivors mainly target the surface glycoprotein GP, and anti-GP neutralizing antibodies have been associated with protection against EBOV infection. In order to elicit protective neutralizing antibodies through vaccination a native-like conformation of the antigen is required. We therefore engineered and expressed in CHO cells several GP variants from EBOV (species Zaire ebolavirus , Mayinga variant), including a soluble GP ΔTM, a mucin-like domain-deleted GP ΔTM-ΔMUC, as well as two GP ΔTM-ΔMUC variants with C-terminal trimerization motifs in order to favor their native trimeric conformation. Inclusion of the trimerization motifs resulted in proteins mimicking GP metastable trimer and showing increased stability. The mucin-like domain appeared not to be critical for the retention of the native conformation of the GP protein, and its removal unmasked several neutralizing epitopes, especially in the trimers. The soluble GP variants inhibited mAbs neutralizing activity in a pseudotype transduction assay, further confirming the proteins' structural integrity. Interestingly, the trimeric GPs, a native-like GP complex, showed stronger affinity for antibodies raised by natural infection in EBOV disease survivors rather than for antibodies raised in volunteers that received the ChAd3-EBOZ vaccine. These results support our hypothesis that neutralizing antibodies are preferentially induced when using a native-like conformation of the GP antigen. The soluble trimeric recombinant GP proteins we developed represent a novel and promising strategy to develop prophylactic vaccines against EBOV and other filoviruses., (Copyright © 2020 Agnolon, Kiseljak, Wurm, Wurm, Foissard, Gallais, Wehrle, Muñoz-Fontela, Bellanger, Correia, Corradin and Spertini.)
- Published
- 2020
- Full Text
- View/download PDF
48. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
- Author
-
Gouveia D, Grenga L, Gaillard JC, Gallais F, Bellanger L, Pible O, and Armengaud J
- Subjects
- Amino Acid Sequence, Animals, Betacoronavirus isolation & purification, COVID-19, Chlorocebus aethiops, Coronavirus Infections diagnosis, Humans, Pandemics, Pneumonia, Viral diagnosis, Proteomics, SARS-CoV-2, Tandem Mass Spectrometry, Vero Cells, Viral Structural Proteins analysis, Betacoronavirus chemistry, Coronavirus Infections virology, Peptides analysis, Pneumonia, Viral virology, Viral Proteins analysis
- Abstract
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a crucial tool for fighting the COVID-19 pandemic. This dataset brief presents the exploration of a shotgun proteomics dataset acquired on SARS-CoV-2 infected Vero cells. Proteins from inactivated virus samples were extracted, digested with trypsin, and the resulting peptides were identified by data-dependent acquisition tandem mass spectrometry. The 101 peptides reporting for six viral proteins were specifically analyzed in terms of their analytical characteristics, species specificity and conservation, and their proneness to structural modifications. Based on these results, a shortlist of 14 peptides from the N, S, and M main structural proteins that could be used for targeted mass-spectrometry method development and diagnostic of the new SARS-CoV-2 is proposed and the best candidates are commented., (© 2020 The Authors. Proteomics published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2020
- Full Text
- View/download PDF
49. A non-targeted LC-HRMS approach for detecting exposure to illegal veterinary treatments: The case of cephalosporins in commercial laying Hens.
- Author
-
Gaugain M, Mompelat S, Fourmond MP, Manceau J, Rolland JG, Laurentie M, Verdon E, Bellanger L, and Hurtaud-Pessel D
- Subjects
- Animals, Cephalosporins metabolism, Feces chemistry, Female, France, Humans, Liver chemistry, Models, Statistical, Ovum chemistry, Veterinary Drugs analysis, Biomarkers analysis, Cephalosporins analysis, Chickens, Chromatography, Liquid, Illicit Drugs analysis, Mass Spectrometry, Substance Abuse Detection veterinary
- Abstract
Cephalosporins are of particular importance in human medicine and should be reserved for second-line curative treatment in the veterinary field to avoid any emerging antimicrobial resistance. Due to misuse of ceftiofur in the poultry sector in France, it is now recommended to completely stop using cephalosporins in this sector. Methods currently used for the control of veterinary practices are mostly based on liquid chromatography coupled to mass spectrometry in a targeted mode, including parent compounds and any major metabolites. The aim of the present study was to evaluate the relevance of untargeted metabolomic approaches to highlight a possible exposure of laying hens to cephalosporins using a predictive model including selected treatment biomarkers. An experimentation carried out on living animals involved the administration of cefquinome and ceftiofur. Three biological matrices-droppings, eggs and liver-were investigated. Metabolites were extracted and analysed by liquid chromatography coupled to high resolution mass spectrometry in a full scan mode. Metabolites impacted by the treatment were selected by using univariate and multivariate statistical analyses. Predictive models built from the potential biomarkers selected in the "droppings" matrix were validated and able to classify "treated" and "control" hens. PLS-DA and logistic regression models were compared and both models gave satisfactory results in terms of prediction. Results were of less interest for other matrices in which only biomarkers of exposure to cefquinome were detected., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
50. Development and evaluation of a genome-wide Coffee 8.5K SNP array and its application for high-density genetic mapping and for investigating the origin of Coffea arabica L.
- Author
-
Merot-L'anthoene V, Tournebize R, Darracq O, Rattina V, Lepelley M, Bellanger L, Tranchant-Dubreuil C, Coulée M, Pégard M, Metairon S, Fournier C, Stoffelen P, Janssens SB, Kiwuka C, Musoli P, Sumirat U, Legnaté H, Kambale JL, Ferreira da Costa Neto J, Revel C, de Kochko A, Descombes P, Crouzillat D, and Poncet V
- Subjects
- Genetic Markers, Genome, Plant, Uganda, Chromosome Mapping, Coffea genetics, Polymorphism, Single Nucleotide
- Abstract
Coffee species such as Coffea canephora P. (Robusta) and C. arabica L. (Arabica) are important cash crops in tropical regions around the world. C. arabica is an allotetraploid (2n = 4x = 44) originating from a hybridization event of the two diploid species C. canephora and C. eugenioides (2n = 2x = 22). Interestingly, these progenitor species harbour a greater level of genetic variability and are an important source of genes to broaden the narrow Arabica genetic base. Here, we describe the development, evaluation and use of a single-nucleotide polymorphism (SNP) array for coffee trees. A total of 8580 unique and informative SNPs were selected from C. canephora and C. arabica sequencing data, with 40% of the SNP located in annotated genes. In particular, this array contains 227 markers associated to 149 genes and traits of agronomic importance. Among these, 7065 SNPs (~82.3%) were scorable and evenly distributed over the genome with a mean distance of 54.4 Kb between markers. With this array, we improved the Robusta high-density genetic map by adding 1307 SNP markers, whereas 945 SNPs were found segregating in the Arabica mapping progeny. A panel of C. canephora accessions was successfully discriminated and over 70% of the SNP markers were transferable across the three species. Furthermore, the canephora-derived subgenome of C. arabica was shown to be more closely related to C. canephora accessions from northern Uganda than to other current populations. These validated SNP markers and high-density genetic maps will be useful to molecular genetics and for innovative approaches in coffee breeding., (© 2018 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.